EP0443719A1
Expired / Lapsed
EP
⏱️ 0.0 years remaining
Novel R106 compounds
Assignee: Takara Shuzo Co Ltd
•
Filing: 1991-01-21
•
Granted: —
•
Expires: 2011-01-21
Abstract
Abstract Novel R106 compounds represented by the following general formula (I): wherein: A₁ is Phe, o-FPhe, m-FPhe, or Tyr; A₂ is MePhe, o-FMePhe, m-FMePhe, MeTyr, Sar, MeSer, or β-oxoMePhe; A₃ is Pro, 4Hyp, or SPro; A₄ is allo-Ile or Nle; A₅ is Leu or Nva; A₆ is β-HOMeVal or Sar; excluding those wherein A₁ is Phe and A₂ is MePhe and A₃ is Pro and A₄ is allo-Ile and A₅ is Leu and A₆ is β-HOMeVal.
Inventors
- 👤 Fumiyo Haruna
- 👤 Hideyo Yamaguchi
- 👤 Teruya Nakamura
- 👤 Katsuhisa Uchida
- 👤 Kazutoh Takesako
- 👤 Katsushige Ikai
- 👤 Junko Yamamoto
- 👤 Kazuo Shimanaka
Bibliographic Details
Application Number
—
Jurisdiction
EP
Data Source
google_patents
Last Synchronized
2026-10-30 05:49
CPC Classifications
C; C07; C07K; C07K11/00; C07K11/02; A; A61; A61P; A61P31/00; A61P31/04
Claims Analysis
Total Claims: 1
Claim 1
Independent Claim
74 words
Novel R106 compounds represented by the following general formula (I): wherein: A₁,is Phe, o-FPhe, m-FPhe, or Tyr; A₂ is MePhe, o-FMePhe, m-FMePhe, MeTyr, Sar, MeSer, or β-oxoMePhe; A₃ is Pro, 4Hyp, or SPro; A₄ is allo-Ile or Nle; A₅ is Leu or Nva; A₆ is β-HOMeVal or Sar; excluding those wherein A₁ is Phe and A₂ is MePhe and A₃ is Pro and A₄ is allo-Ile and A₅ is Leu and A₆ is β-HOMeVal.
References Cited (Backward Citations)
EP0060121A1
Cited
EP0352092A2
Cited
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.